Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian H Frazer

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|February 27, 2004
Mutations in TAP genes are common in cervical carcinomasNina L Fowler, Ian H Frazer
Journal of the National Cancer Institute. Monographs|June 17, 2003
Chapter 16: Prophylactic human papillomavirus vaccinesDouglas R Lowy, Ian H Frazer
Current Opinion in Immunology|February 13, 2007
HPV vaccines: the beginning of the end for cervical cancerGraham R Leggatt, Ian H Frazer
The Medical Journal of Australia|May 24, 2021
The Australian Academy of Health and Medical Sciences: an authoritative, independent voice in the Australian landscapeIngrid E Scheffer, Ian H Frazer
Zhonghua Yi Xue Za Zhi|July 23, 2002
[Immunogenicity study of HPV 6b virus-like particles]Yuehua Liu, Xiaosong Liu, Ian H Frazer
The FEBS Journal|January 15, 2011
Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysisFang Zhou, Graham R Leggatt, Ian H Frazer
Experimental Dermatology|July 16, 2009
Keratinocytes efficiently process endogenous antigens for cytotoxic T-cell mediated lysisFang Zhou, Ian H Frazer, Graham R Leggatt
Cell|March 10, 2018
No Vacillation on HPV VaccinationDouglas Sipp, Ian H Frazer, John E J Rasko
Cell Death & Disease|June 2, 2017
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicityPurnima Bhat, Graham Leggatt, Nigel Waterhouse, et al.
European Journal of Immunology|November 1, 2007
Prevention of cancer through immunization: Prospects and challenges for the 21st centuryIan H Frazer, Doug R Lowy, John T Schiller
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|February 27, 2004
Mutations in TAP genes are common in cervical carcinomasNina L Fowler, Ian H Frazer
Journal of the National Cancer Institute. Monographs|June 17, 2003
Chapter 16: Prophylactic human papillomavirus vaccinesDouglas R Lowy, Ian H Frazer
Current Opinion in Immunology|February 13, 2007
HPV vaccines: the beginning of the end for cervical cancerGraham R Leggatt, Ian H Frazer
The Medical Journal of Australia|May 24, 2021
The Australian Academy of Health and Medical Sciences: an authoritative, independent voice in the Australian landscapeIngrid E Scheffer, Ian H Frazer
Zhonghua Yi Xue Za Zhi|July 23, 2002
[Immunogenicity study of HPV 6b virus-like particles]Yuehua Liu, Xiaosong Liu, Ian H Frazer
The FEBS Journal|January 15, 2011
Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysisFang Zhou, Graham R Leggatt, Ian H Frazer
Experimental Dermatology|July 16, 2009
Keratinocytes efficiently process endogenous antigens for cytotoxic T-cell mediated lysisFang Zhou, Ian H Frazer, Graham R Leggatt
Cell|March 10, 2018
No Vacillation on HPV VaccinationDouglas Sipp, Ian H Frazer, John E J Rasko
Cell Death & Disease|June 2, 2017
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicityPurnima Bhat, Graham Leggatt, Nigel Waterhouse, et al.
European Journal of Immunology|November 1, 2007
Prevention of cancer through immunization: Prospects and challenges for the 21st centuryIan H Frazer, Doug R Lowy, John T Schiller
Pageof 19